Viewing Study NCT01311232

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2026-04-03 @ 8:44 PM
Study NCT ID: NCT01311232
Status: COMPLETED
Last Update Posted: 2017-10-27
First Post: 2011-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab
Sponsor: Samsung Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Patients With Diffuse Large B-cell Lymphoma or Follicular Lymphoma View
None Patients Treated With Rituximab-CHOP or Rituximab-CVP View
Keywords:

Keywords

Keyword Brief Keyword Text View
None rituximab, lymphoma, hepatitis B virus View